EDGAR Filing Documents for 0001193125-17-085130

Form 8-K - Current report:

SEC Accession No. 0001193125-17-085130

Filing Date

2017-03-16

Accepted

2017-03-16 13:55:33

Documents

Period of Report

2017-03-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d362679d8k.htm	8-K	20543
2	EX-1.1	d362679dex11.htm	EX-1.1	167346
3	EX-4.1	d362679dex41.htm	EX-4.1	109990
4	EX-4.2	d362679dex42.htm	EX-4.2	110095
5	EX-5.1	d362679dex51.htm	EX-5.1	6926
6	EX-10.1	d362679dex101.htm	EX-10.1	5656
7	EX-99.1	d362679dex991.htm	EX-99.1	5595
8	EX-99.2	d362679dex992.htm	EX-99.2	6611
9	GRAPHIC	g362679g52u78.jpg	GRAPHIC	2579
	Complete submission text file	0001193125-17-085130.txt		437616

Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545

Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600

Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)